Voiding and storage domain-specific symptom score outcomes after prostate artery embolization for lower urinary tract symptoms and urinary retention

Urology ◽  
2021 ◽  
Author(s):  
Raj Ayyagari ◽  
Taylor Powell ◽  
Lawrence Staib ◽  
Bing Liu ◽  
Shivank Bhatia ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Retention ◽  
Lower Urinary Tract ◽  
Artery Embolization ◽  
Specific Symptom ◽  
Prostate Artery Embolization ◽  
Domain Specific ◽  
Urinary Tract Symptoms ◽  
And Storage ◽  
Lower Urinary

scholarly journals Prostate Artery Embolization for Lower Urinary Tract Symptoms in Men Unfit for Surgery

Diagnostics ◽  
2019 ◽  
Vol 9 (2) ◽  
pp. 46 ◽  
Author(s):  
Malling ◽  
Lönn ◽  
Jensen ◽  
Lindh ◽  
Frevert ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Retention ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Specific Antigen ◽  
P Value ◽  
Artery Embolization ◽  
Prostate Artery Embolization ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Nearly one in three men develop lower urinary tract symptoms (LUTS) and 10% clinically progress despite medication. Transurethral resection of the prostate (TURP) is the reference standard for symptoms refractory to medical treatment. However, some patients cannot tolerate TURP for medical (e.g., comorbidity) or technical (e.g., large prostate) reasons. This study estimated the safety and effect of prostate artery embolization (PAE) in men unfit for surgery. A prospective, single-centre trial including men with LUTS or urinary retention secondary to benign prostatic hyperplasia (BPH) who were unfit for surgery. The primary objective was to treat urinary retention and LUTS. Outcome measures included International Prostate Symptom Score (IPSS), quality of life (IPSS-QoL), International Index of Erectile Function (IIEF-5), prostate volume (PV), prostate-specific antigen (PSA), peak void flow (Qmax), post-void residual (PVR), and complications. A p-value < 0.05 was considered statistically significant. Eleven consecutive patients with a mean age of 75.2 (SD ± 8.2) underwent PAE. Catheter removal was successful in 60%. IPSS-QoL improved 4.5 points (95% CI: −5.6; −3.4), and PV was reduced by 26.2 cm3 (95% CI: −50.9; −2.3). None of the remaining outcomes changed. No major complications occurred. PAE was effective and safe for LUTS and urinary retention associated with BPH in men unfit for surgery.

scholarly journals Prostate artery embolization: a new, minimally invasive treatment for lower urinary tract symptoms secondary to prostate enlargement

2017 ◽  
Vol 9 (8) ◽  
pp. 209-216 ◽  
Author(s):  
Drew Maclean ◽  
Ben Maher ◽  
Sachin Modi ◽  
Mark Harris ◽  
Jonathan Dyer ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Benign Prostatic Obstruction ◽  
Artery Embolization ◽  
Invasive Treatment ◽  
Prostate Artery Embolization ◽  
Efficacious Treatment ◽  
Prostate Enlargement ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Prostate artery embolization (PAE) is emerging as a safe and efficacious treatment which approaches benign prostatic obstruction (BPO) from a unique perspective. This brings with it distinct advantages and solutions, which we discuss along with cost, evidence, complications and disadvantages.

Sign in / Sign up

Export Citation Format

Share Document